Patient Guide: A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 38 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07092865
Status: 🟢 Enrolling Now
Condition: Respiratory Syncytial Virus Infections
Phase: Phase II

Find a Study Location Near You

This study is available at 38 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Lexington, Kentucky
  • • St Louis, Missouri
  • • St Louis, Missouri
  • • And 35 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant - Join Clinical Trial NCTNCT07092865

How to Join This Clinical Trial - NCTNCT07092865

Learn how to participate in this Phase II trial studying an investigational therapy for Respiratory Syncytial Virus Infections. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Respiratory Syncytial Virus Infections. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Respiratory Syncytial Virus Infections
Treatment Being Tested
Investigational treatment
Study Phase
Phase II - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07092865 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 38 locations. Find a study site near you:

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: Contact for availability

Clinical Research Site

St Louis, Missouri 63110-1035 - United States

Status: Contact for availability

Clinical Research Site

St Louis, Missouri 63110 - United States

Status: Contact for availability

Clinical Research Site

Omaha, Nebraska 68198 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10065 - United States

Status: Contact for availability

Clinical Research Site

Pittsburgh, Pennsylvania 15213 - United States

Status: Contact for availability

Clinical Research Site

Temple, Texas 76502 - United States

Status: Contact for availability

Clinical Research Site

Camperdown, New South Wales 2050 - Australia

Status: Contact for availability

Clinical Research Site

Birtinya, Queensland 4556 - Australia

Status: Contact for availability

Clinical Research Site

Herston, Queensland 4029 - Australia

Status: Contact for availability

And 28 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase II clinical trial for Respiratory Syncytial Virus Infections:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation